These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33358454)

  • 1. [Prolactinoma causing erectile dysfunction].
    Muadi J; Sánchez A
    Rev Int Androl; 2021; 19(4):285-288. PubMed ID: 33358454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of Chronic LH-Testosterone Axis Suppression in Male Macroprolactinomas With Normoprolactinemia on Cabergoline.
    Sehemby M; Lila AR; Sarathi V; Shah R; Sankhe S; Jaiswal SK; Ramteke-Jadhav S; Patil V; Shah N; Bandgar T
    J Clin Endocrinol Metab; 2020 Dec; 105(12):. PubMed ID: 32942295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pituitary prolactinoma with severe erectile dysfunction as the initial symptom: diagnosis and treatment of 4 cases].
    Jiang T; Zheng L; Su XM; Peng JQ; Sun DC; Li QL; Zhang ZW; Wang FP; Jiang H
    Zhonghua Nan Ke Xue; 2013 Feb; 19(2):141-3. PubMed ID: 23441455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recovery pattern of hypothalamo-pituitary-testicular axis in patients with macroprolactinomas after treatment with cabergoline.
    Walia R; Bhansali A; Dutta P; Khandelwal N; Sialy R; Bhadada S
    Indian J Med Res; 2011 Sep; 134(3):314-9. PubMed ID: 21985814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recovery of persistent hypogonadism by clomiphene in males with prolactinomas under dopamine agonist treatment.
    Ribeiro RS; Abucham J
    Eur J Endocrinol; 2009 Jul; 161(1):163-9. PubMed ID: 19359408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperprolactinemia in children and adolescents and longterm follow-up results of prolactinoma cases: a single-centre experience.
    Kontbay T; Şıklar Z; Özsu E; Uyanık R; Bilici E; Ceran A; Berberoğlu M
    Turk J Pediatr; 2022; 64(5):892-899. PubMed ID: 36305439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocrine screening in 1,022 men with erectile dysfunction: clinical significance and cost-effective strategy.
    Buvat J; Lemaire A
    J Urol; 1997 Nov; 158(5):1764-7. PubMed ID: 9334596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperprolactinaemia due to hypothalamic-pituitary disease or drug-induced in patients with erectile dysfunction.
    Venetikou MS; Lambou T; Gizani D
    Andrologia; 2008 Aug; 40(4):240-4. PubMed ID: 18727734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What causes a prolactinoma to be aggressive or to become a pituitary carcinoma?
    Phillips J; East HE; French SE; Melcescu E; Hamilton RD; Nicholas WC; Fratkin JF; Parent AD; Luzardo G; Koch CA
    Hormones (Athens); 2012; 11(4):477-82. PubMed ID: 23422771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical therapy of macroprolactinomas in males: I. Prevalence of hypopituitarism at diagnosis. II. Proportion of cases exhibiting recovery of pituitary function.
    Sibal L; Ugwu P; Kendall-Taylor P; Ball SG; James RA; Pearce SH; Hall K; Quinton R
    Pituitary; 2002; 5(4):243-6. PubMed ID: 14558672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and drug therapy of prolactinoma.
    Ciccarelli E; Camanni F
    Drugs; 1996 Jun; 51(6):954-65. PubMed ID: 8736617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of nNOS and ultrastructural changes in the penile tissue of rats with prolactinoma-induced erectile dysfunction].
    Weng BW; Hou SC; Zhu H; Xu L; Luan X; Qi HY; Wang WM; Liu W; Sun LJ
    Zhonghua Nan Ke Xue; 2015 Oct; 21(10):871-6. PubMed ID: 26665672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperprolactinemia diagnosis in elderly men: a cohort of 28 patients over 65 years.
    Shimon I; Hirsch D; Tsvetov G; Robenshtok E; Akirov A; Fraenkel M; Eizenberg Y; Herzberg D; Barzilay-Yoseph L; Livner A; Friedrich I; Manisterski Y; Ishay A; Yoel U; Masri H
    Endocrine; 2019 Sep; 65(3):656-661. PubMed ID: 31154607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Giant prolactinomas in men: efficacy of cabergoline treatment.
    Corsello SM; Ubertini G; Altomare M; Lovicu RM; Migneco MG; Rota CA; Colosimo C
    Clin Endocrinol (Oxf); 2003 May; 58(5):662-70. PubMed ID: 12699451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bromocriptine monotherapy of a prolactinoma causing erectile dysfunction].
    López Cubillana P; Hita Rosino E; Asensio Egea L; Rigabert Montiel M; Hita Villaplana G; Server Pastor G; Server Falgás G
    Arch Esp Urol; 1997 Jun; 50(5):526-8. PubMed ID: 9382597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cabergoline treatment in men with psychogenic erectile dysfunction: a randomized, double-blind, placebo-controlled study.
    Nickel M; Moleda D; Loew T; Rother W; Pedrosa Gil F
    Int J Impot Res; 2007; 19(1):104-7. PubMed ID: 16728967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ectopic Cavernous Sinus Microprolactinoma Treated Medically.
    Minns RM; Barranco-Trabi J; Yiu AC; Hussain A; Elegino-Steffens DU
    Mil Med; 2023 May; 188(5-6):1304-1306. PubMed ID: 35758408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of hypogonadism in a male patient with a giant prolactinoma: a clinical paradox.
    Tamagno G; Daly AF; Deprez M; Vroonen L; Andris C; Martin D; Beckers A
    Ann Endocrinol (Paris); 2008 Feb; 69(1):47-52. PubMed ID: 18082643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pituitary apoplexy of a giant prolactinoma during pregnancy.
    Khaldi S; Saad G; Elfekih H; Ben Abdelkrim A; Ach T; Kacem M; Chaieb M; Maaroufi A; Hasni Y; Ach K
    Gynecol Endocrinol; 2021 Sep; 37(9):863-866. PubMed ID: 34124989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for macroprolactinaemia and pituitary imaging studies.
    Hauache OM; Rocha AJ; Maia AC; Maciel RM; Vieira JG
    Clin Endocrinol (Oxf); 2002 Sep; 57(3):327-31. PubMed ID: 12201824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.